Vistin Pharma ASA (OSL:VISTN) Net Interest Margin (Bank Only) %


OSL:VISTN Vistin Pharma ASA OSL:VISTN
80 GF Score
Price kr20.40
GF Value kr25.61
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Vistin Pharma ASA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

OSL:VISTN
80GF Score
Vistin Pharma ASA OSL:VISTN
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vistin Pharma ASA (OSL:VISTN) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of kr20.40 is trading 20.3% below its estimated GF Value™ of kr25.61. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for OSL:VISTN:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: kr25.61 vs. price of kr20.40 (20.3% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the OSL:VISTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
80GF Score

Get the complete analysis for OSL:VISTN

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.40
Price
kr25.61
GF Value